Former Executive Vice President and Chief Commercial Officer · Harmony Biosciences Holdings, Inc. (HRMY)

Jeffrey Dierks

Jeffrey Dierks, the former Executive Vice President and Chief Commercial Officer at Harmony Biosciences Holdings, Inc., received total compensation of $2,346,945 for fiscal year 2025. His compensation consisted of a base salary of $132,263 and stock-based compensation of $1,717,195, with no cash bonus disclosed.

FY2025 is the first fiscal year CompBrief holds for Jeffrey Dierks as a named executive officer of Harmony Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,346,945

Compensation figures as of the proxy filed April 3, 2026 (DEF 14A).

Jeffrey Dierks compensation by year

Harmony Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Harmony Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$132,263
Bonus$0
Stock awards$511,235
Option awards$1,205,960
Non-equity incentive$0
Pension and deferred compensation$0
All other$497,487
Total$2,346,945

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Harmony Biosciences Holdings, Inc. DEF 14A filed April 3, 2026, accession 0001104659-26-039449, and prior-year filings. Open the filing on EDGAR.

Change-in-control & termination

estimated payments Harmony Biosciences discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$476,215$1,594,418$0$2,070,633

Per the Potential Payments Upon Termination or Change in Control table in Harmony Biosciences Holdings, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

Harmony Biosciences’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Jeffrey DaynoPresident and Chief Executive Officer$7,899,535
Adam ZaeskeExecutive Vice President and Chief Commercial Officer$3,664,228
Sandip KapadiaExecutive Vice President, Chief Financial Officer and Chief Administrative Officer$3,204,319
Jeffrey Dierks · this pageFormer Executive Vice President and Chief Commercial Officer$2,346,945
Kumar BudurExecutive Vice President and Chief Medical and Scientific Officer$2,279,439
Andrew SerafinExecutive Vice President and Chief Strategy Officer$2,009,277

The full Harmony Biosciences compensation record

free company brief

This page is one person within Harmony Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Harmony Biosciences's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Harmony Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy